Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
British American Tobacco
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Global Regulation And Shifting Norms Will Curtail Prospects
Key Takeaways Aggressive regulation, shifting consumer attitudes, and ESG-driven divestment are pressuring BAT's traditional revenue streams, valuation, and long-term profitability. Exposure to emerging markets heightens volatility, while illicit competition and bans constrain diversification beyond legacy tobacco products.
View narrative
UK£26.50
FV
59.5% overvalued
intrinsic discount
0.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
2 days ago
author updated this narrative
Chugai Pharmaceutical
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Global Pricing Cuts And Pipeline Delays Will Dim Prospects
Key Takeaways Reliance on a narrow set of high-earning drugs and pipeline uncertainty increases exposure to competitive threats and potential revenue volatility. Ongoing price pressures, biosimilar competition, and major capital investments risk squeezing margins, straining cash flow, and impacting long-term growth prospects.
View narrative
JP¥6.10k
FV
0.1% undervalued
intrinsic discount
1.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
SoftBank Group
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Rising Rates And Antitrust Risks Will Crush AI Investments
Key Takeaways Global macroeconomic and regulatory challenges threaten SoftBank's investment strategy, pressuring earnings, portfolio valuations, and potential exits from key holdings. High-risk, concentrated investments in AI and underperforming IPOs create unpredictable cash flows and could jeopardize long-term shareholder returns.
View narrative
JP¥8.00k
FV
73.3% overvalued
intrinsic discount
3.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
EssilorLuxottica Société anonyme
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Digital Commerce And Regulatory Risks Will Undercut Smart Eyewear
Key Takeaways Growing digital competition and shifting consumer trends threaten traditional sales channels, premium market focus, and long-term pricing power. Expansion into MedTech and innovative eyewear increases operational complexity, regulatory exposure, and execution risk, pressuring profitability and margin sustainability.
View narrative
€191.33
FV
32.2% overvalued
intrinsic discount
5.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
ACWA Power
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising Execution Risks In Volatile Regions Will Derail Aggressive Project Ambitions
Key Takeaways Rapid expansion and significant geographic concentration expose ACWA Power to high execution, regulatory, and operational risks impacting revenue stability. Heightened competition, rising financing costs, and supply chain disruptions threaten to erode margins and delay project deliveries across its pipeline.
View narrative
ر.س110.00
FV
96.8% overvalued
intrinsic discount
23.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Safran
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Rising Emissions Regulations And Market Risks Will Erode Profitability
Key Takeaways Safran faces profitability and market share risks from decarbonization demands, disruptive propulsion technologies, and potential underperformance in next-generation investments. Geopolitical pressures, restricted export access, workforce shortages, and heavy exposure to cyclical air travel threaten overall revenue stability and margin strength.
View narrative
€221.49
FV
31.5% overvalued
intrinsic discount
8.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
CNOOC
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Fossil Fuel Demand Will Fall As Renewables And Regulations Intensify
Key Takeaways Rising regulatory, geopolitical, and environmental pressures threaten CNOOC's growth, profitability, and access to key markets and technologies. Heavy focus on offshore oil exploration exposes the company to elevated operational, legal, and transition risks, with limited progress in renewable energy diversification.
View narrative
HK$13.17
FV
40.9% overvalued
intrinsic discount
-4.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Airbus
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Rising Climate And Supply Chain Risks Will Erode Aerospace Margins
Key Takeaways Tightening climate regulations and green technology challenges threaten future revenue growth, profitability, and margin improvement prospects. Supply chain fragility and supplier consolidation increase costs, operational risks, and working capital strains, intensifying earnings volatility.
View narrative
€140.00
FV
25.9% overvalued
intrinsic discount
9.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
2 days ago
author updated this narrative
Mitsubishi UFJ Financial Group
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Fintech Rivalry And Aging Markets Will Squeeze Margins
Key Takeaways Ongoing low interest rates, demographic headwinds, and legacy costs constrain MUFG's domestic growth and profitability, while digital challengers weaken core banking revenues. Overseas expansion faces regulatory and competitive pressures, and heavy exposure to low-yield assets limits return improvement and adds further risk to future earnings.
View narrative
JP¥1.67k
FV
27.5% overvalued
intrinsic discount
3.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies